Related Experiment Video
Updated: Feb 6, 2026

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
Facilitation of MrgprD by TRP-A1 promotes neuropathic pain
Changming Wang1,2,3,4, Leying Gu1,2,3,4, Yonglan Ruan1,2,3,4
1School of Medicine and Life Sciences, Nanjing University of Chinese Medicine, Nanjing, China.
Abstract:
Neuropathic pain remains a therapeutic challenge because of its complicated mechanisms. Mas-related GPCR D (MrgprD) is specifically expressed in small-diameter, nociceptive neurons of dorsal root ganglia (DRGs) and is implicated in pain modulation. However, the underlying mechanism of MrgprD involved in neuropathic pain remains elusive. In this study, we used behavioral experiments and physiologic examination methods to investigate the role of MrgprD in chronic constriction injury (CCI)-induced neuropathic pain. We found that MrgprD is necessary for the initiation of mechanical hypersensitivity and cold allodynia, but not for heat allodynia. Moreover, we demonstrated that transient receptor potential cation channel (TRP)-A1 was the ion channel downstream of MrgprD, and the β-alanine-induced calcium signal was attributed mostly to TRP-A1 function. We further showed that PKA serves as a downstream mediator of β-alanine-activated MrgprD signaling to activate TRP-A1 in DRG neurons and in human embryonic kidney 293 cells, to coexpress MrgprD and TRP-A1 plasmids. Finally, we found that the β-alanine-induced pain behavior was increased, whereas the itching behavior was unchanged in CCI models compared with sham-injured animals. Knockout of TRPA1 also attenuated the β-alanine-induced pain behavior in CCI models. In conclusion, MrgprD is essential in cold allodynia in CCI-induced neuropathic pain through the PKA-TRP-A1 pathway. TRP-A1 facilitates MrgprD to development of neuropathic pain. Our findings reveal a novel mechanism of neuropathic pain formation and highlight MrgprD as a promising drug target for the treatment of neuropathic pain.-Wang, C., Gu, L., Ruan, Y., Geng, X., Xu, M., Yang, N., Yu, L., Jiang, Y., Zhu, C., Yang, Y., Zhou, Y., Guan, X., Luo, W., Liu, Q., Dong, X., Yu, G., Lan, L., Tang, Z. Facilitation of MrgprD by TRP-A1 promotes neuropathic pain.
Insights
Mas-related GPCR D (MrgprD) is crucial for neuropathic pain, specifically cold allodynia, by activating the TRP-A1 channel. This pathway highlights MrgprD as a potential therapeutic target for treating neuropathic pain.
Area of Science:
- Neuroscience
- Pain Research
- Molecular Biology
Background:
- Neuropathic pain presents complex therapeutic challenges due to poorly understood mechanisms.
- Mas-related GPCR D (MrgprD) is expressed in pain-sensing neurons but its role in neuropathic pain is unclear.
Purpose of the Study:
- To investigate the role of MrgprD in chronic constriction injury (CCI)-induced neuropathic pain.
- To elucidate the downstream signaling pathway of MrgprD in pain modulation.
Main Methods:
- Behavioral experiments and physiological examinations in rodent models of neuropathic pain.
- Investigated the involvement of Transient Receptor Potential Cation Channel A1 (TRP-A1) and Protein Kinase A (PKA) in MrgprD signaling.
- Utilized gene knockout models and cell co-expression systems.
Main Results:
- MrgprD is essential for mechanical hypersensitivity and cold allodynia, but not heat allodynia, in CCI models.
- TRP-A1 acts as a downstream ion channel for MrgprD, mediating β-alanine-induced calcium signals.
- PKA is a key mediator in the MrgprD-TRP-A1 pathway, promoting neuropathic pain development.
Conclusions:
- MrgprD plays a critical role in CCI-induced neuropathic pain, particularly cold allodynia, via the PKA-TRP-A1 pathway.
- TRP-A1 facilitates MrgprD's role in the development of neuropathic pain.
- MrgprD represents a promising therapeutic target for neuropathic pain treatment.
More Related Videos
10:52Chronic Constriction Injury of the Rat's Infraorbital Nerve IoN-CCI to Study Trigeminal Neuropathic Pain
Published on: September 21, 2015
08:16Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies
Published on: October 6, 2022
Related Concept Videos
Facilitated Transport
Facilitated Transport
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
Social Facilitation
Repressible Operon: trp Operon